Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Perspectives on anticoagulation across cardiovascular disease Anticoagulants ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by